KCI Announces First-of-its-Kind Negative Pressure Wound Therapy

Agreement with Highmark to Improve Patient Engagement, Raise Adherence and Lower Costs

 

SAN ANTONIO–(BUSINESS WIRE)–KCI, an Acelity Company, a global leader in advanced wound management, and Highmark Inc., a national diversified health care insurance provider, today announced they have entered into a performance-based agreement for the KCI iOn PROGRESS™ Remote Therapy Monitoring Program which aims to improve overall patient experience, while lowering costs through increased engagement and adherence. Used in conjunction with the ACTIV.A.C.™ Therapy System, iOn PROGRESS™ Remote Therapy Monitoring Program consists of 3 key components:

 

  • Monitoring: A proprietary remote monitoring module attached to the ACTIV.A.C.™ Therapy device enables secure transmission of therapy data to KCI.
  • Engagement: A highly trained team of KCI Virtual Therapy Specialists (VTS) analyze the data and interact directly with patients and healthcare professionals to support adherence.
  • Adherence: 73% of patients demonstrated an increase in hours of NPWT use per day following an adherence call from a Virtual Therapy Specialist. A lower average 90-day wound-related cost was associated with those receiving remote therapy monitoring.1

The agreement is the first-of-its-kind for negative pressure wound therapy (NPWT) and creates a performance-based payment structure for reducing total wound care costs. The partnership is a result of a diligent evaluation process by Highmark to understand how the iOn PROGRESS™ Remote Therapy Monitoring Program impacts its members in alignment with their commitment to improve quality while lowering total cost of care …. read more